News
STAT+: AbbVie wins FDA nod for Parkinson’s pill
The FDA has approved AbbVie’s once-daily Parkinson’s pill for sales, based on a late-stage study that showed the drug helped improve symptoms.
More in Health
- 5 tips for parents worried about their kids' screen time and online safety NPR — Health
- Ten NHS staff removed over Noah Woods data breach BBC News — Health
- Pennsylvania Measles Outbreak Grows to Nearly 900 Cases The New York Times — Health
- Three in four UK GPs ‘too busy to talk to their patients in depth’ The Guardian — Society
- WHO Director-General visits Jordan to recognize strong collaboration on health system delivery, emergency relief and advancing mental health World Health Organization